Stock SUVENPHAR SUVEN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Suven Pharmaceuticals Limited

Equities

SUVENPHAR

INE03QK01018

End-of-day quote NSE India S.E.
Other stock markets
 06:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
635.6 INR +0.81% Intraday chart for Suven Pharmaceuticals Limited +0.55% -12.07%
May. 30 Transcript : Suven Pharmaceuticals Limited, Q4 2024 Earnings Call, May 30, 2024
May. 30 Suven Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

Evolution of the average Target Price on Suven Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

0160da23461c018ea02df747d4.GV6xkf4aaDElkOT7zfwlhGU0eRoq-Ymt012ONPMShfQ.aC_Ux6FrOlpf1bbMo55x0UgGEGBfuMHuoQXqBMR4x65rFYiosk86VxbCiw~86c48a3d04f8b98b3d3440a0d044d2e5

Analyst Recommendations on Suven Pharmaceuticals Limited

INDIA STOCKS-India's Nifty 50, Sensex scale new peaks on hopes of Fed rate pause RE
Indian shares set to open higher on rising hopes of a Fed rate pause RE
Crisil Assigns A+ Rating on Suven Pharmaceuticals' Long-term Bank Financing; Rating Under Watch Developing MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
635.6 INR
Average target price
670.5 INR
Spread / Average Target
+5.50%
High Price Target
770 INR
Spread / Highest target
+21.15%
Low Price Target
571 INR
Spread / Lowest Target
-10.16%

Consensus detail

Consensus revision (last 18 months)

Ratings for Suven Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock
  4. Consensus Suven Pharmaceuticals Limited